Investment
Features
FeesSafety
Academy
More
Pluang+

AppFolio shares rise 2.46% amid insider sale and strong AI-driven growth outlook

Market News
14 Jul 2026
Andrew Wynn
View Source
Bullish
pluang ai news

AppFolio, Inc. saw its stock price increase by 2.46% to $179.90, outperforming major indices, driven by strong momentum and AI-focused growth strategies. Insider DUCA MAURICE J sold 3,500 shares worth $630,525 but still holds over 88,000 shares. Analysts expect a 21% rise in earnings per share to $1.67 and 17.58% revenue growth to $277 million, reflecting confidence in the company's AI-driven property management software. Investors are keenly awaiting the earnings report on July 23, 2026, to confirm these optimistic projections.

More News

Halper Sadeh LLC probes fairness of major mergers and sales for NEE, CRBG, RMAX, and APGE shareholders.

Halper Sadeh LLC probes fairness of major mergers and sales for NEE, CRBG, RMAX, and APGE shareholders.

Halper Sadeh LLC is investigating whether shareholders of NextEra Energy (NEE), Corebridge Financial (CRBG), RE/MAX Holdings (RMAX), and Apogee Therapeutics (APGE) are receiving fair deals in their companies' proposed mergers or sales. The firm highl...

Market News
Bearish
57 minutes ago
Law firm investigates if NextCure shareholders get a fair price in merger with Avere Therapeutics.

Law firm investigates if NextCure shareholders get a fair price in merger with Avere Therapeutics.

Halper Sadeh LLC is investigating the merger between NextCure, Inc. and Avere Therapeutics, Inc. to determine if NextCure's shareholders are receiving a fair price. The firm questions whether NextCure's board fulfilled their duties by securing the be...

Market News
Bearish
1 hour ago
ASML expects strong Q2 earnings with 15% EPS growth amid market dominance and export challenges.

ASML expects strong Q2 earnings with 15% EPS growth amid market dominance and export challenges.

ASML Holding N.V., Europe's largest semiconductor equipment supplier, is set to report Q2 earnings on July 15, 2026, with analysts forecasting an EPS of $7.92 and revenue of $10.25 billion, reflecting a 15% year-over-year EPS increase. The company pl...

Company Fundamentals
Bullish
1 hour ago
Erasca shares rise on positive cancer trial data and Jefferies' price target hike amid $550M share offering.

Erasca shares rise on positive cancer trial data and Jefferies' price target hike amid $550M share offering.

Erasca Inc., a precision oncology firm, saw its stock jump 8.94% to $19.50 after positive preliminary data showed a 57% response rate for its pancreatic cancer drug candidate ERAS-0015. Jefferies raised its price target to $24, implying a 23% upside....

Market News
Bullish
2 hours ago
Verizon stock downgraded amid fears of competition from SpaceX's Starlink in U.S. mobile market

Verizon stock downgraded amid fears of competition from SpaceX's Starlink in U.S. mobile market

HSBC downgraded Verizon stock to 'Reduce' due to concerns over competition from SpaceX's Starlink entering the U.S. mobile market. Bernstein also lowered its price target, citing long-term threats to Verizon's profits and growth. Analyst Jim Cramer e...

Analyst Insights
Bearish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App